Delivery Order SPE2DB25D3018-SPE2DB25FUYEY
- Not listed
- The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,331.42 and is scheduled for completion by August 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,043.85 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, a contraceptive pharmaceutical product, with a contract value of $1,130.61. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, utilizing firm fixed price contracting without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- This delivery order, awarded to AmerisourceBergen Drug Corp on February 12, 2025, provides for the supply of Etonogestrel-EE vaginal ring contraceptives to support military and federal healthcare needs. The $1,673.52 contract represents a firm fixed-price delivery order with an ultimate completion date of February 13, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis through the Defense...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $77,146.62 firm fixed-price contract is for the supply of etonogestrel-EE vaginal rings, a type of contraceptive. The contract has an ultimate completion date of August 19, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYEYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs, likely for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages this comprehensive prime contract vehicle to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs globally. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition and established pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/8/25 |